BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10774109)

  • 1. [Benign epithelial inclusions in pelvic lymph nodes. 2 case reports].
    Alvarado Cabrero I; Sosa Romero A
    Ginecol Obstet Mex; 2000 Feb; 68():77-81. PubMed ID: 10774109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma.
    Cohn DE; Folpe AL; Gown AM; Goff BA
    Gynecol Oncol; 1998 Feb; 68(2):210-3. PubMed ID: 9514806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
    Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
    Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.
    Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY
    Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-needle aspiration biopsy and intraoperative cytologic smear findings in a case of benign mesothelial-cell inclusions involving a lymph node: case report and review of the literature.
    Paull G; Mosunjac M
    Diagn Cytopathol; 2003 Sep; 29(3):163-6. PubMed ID: 12951686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
    Kadar N; Krumerman M
    Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign müllerian inclusions in pelvic and paraaortic lymph nodes.
    Reich O; Tamussino K; Haas J; Winter R
    Gynecol Oncol; 2000 Aug; 78(2):242-4. PubMed ID: 10926810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
    Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
    Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian tumors of low malignant potential: an intra- and retroperitoneal disease?].
    Maassen V
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):163-8. PubMed ID: 8385641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic and non-neoplastic mesothelial proliferations in pelvic lymph nodes.
    Hsu YK; Parmley TH; Rosenshein NB; Bhagavan BS; Woodruff JD
    Obstet Gynecol; 1980 Jan; 55(1):83-8. PubMed ID: 7352068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign epithelial inclusions in peripancreatic lymph nodes: a report of two cases and review of the literature.
    Zheng Z; Molinari M; Sapp H; Jung SM; Wanless I; Huang WY
    Int J Surg Pathol; 2012 Dec; 20(6):570-6. PubMed ID: 23045332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?
    Ayhan A; Gultekin M; Dursun P; Dogan NU; Aksan G; Guven S; Velipasaoglu M; Yuce K
    Gynecol Oncol; 2008 Feb; 108(2):428-32. PubMed ID: 18249232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor--a report of two cases associated with ovarian neoplasms.
    Clement PB; Young RH; Oliva E; Sumner HW; Scully RE
    Mod Pathol; 1996 Sep; 9(9):879-86. PubMed ID: 8878019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial inclusions in the lymph nodes. Diagnostic, histogenetic, and prognostic problems.
    Gricouroff G
    Diagn Gynecol Obstet; 1982; 4(4):285-93. PubMed ID: 7166115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endosalpingiosis of the axillary lymph nodes--primary or metastatic tumour?].
    Stolnicu S; Mocan S; Coros MF; Rădulescu D; Bara T
    Chirurgia (Bucur); 2005; 100(3):297-300. PubMed ID: 16106940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.